Advertisement

Topics

Latest "ChemBridge Research Laboratories, Inc." News Stories

09:13 EST 17th December 2018 | BioPortfolio

Here are the most relevant search results for "ChemBridge Research Laboratories, Inc." found in our extensive news archives from over 250 global news sources.

More Information about ChemBridge Research Laboratories, Inc. on BioPortfolio

In addition to our news stories we have dozens of PubMed Articles about ChemBridge Research Laboratories, Inc. for you to read. Along with our medical data and news we also list ChemBridge Research Laboratories, Inc. Clinical Trials, which are updated daily. BioPortfolio also has a large database of ChemBridge Research Laboratories, Inc. Companies for you to search.

Showing "ChemBridge Research Laboratories" News Articles 1–25 of 29,000+

Monday 17th December 2018

Vernalis Research, a Ligand Company, Achieves Success Milestone in Collaboration with Asahi Kasei Pharma

Vernalis Research, a Ligand Company, announced the achievement of a £1 million success milestone in its drug discovery collaboration with Asahi Kasei Pharma (AKP). This collaboration with AKP was initiated in October 2013 and utilises Vernalis’ fragment and structure-based drug discovery platform against an undisclosed target for rheumatoid art...


iChek Adds New Advisory Board Member

Recognized visionary expert added to expand company vision and strategic development iChek, a pioneer in the development of an active contact lens technology for glucose and hydration monitoring, is pleased to announce today the addition of Steve Martin to its advisory board. Mr. Martin is a nationally recognized and accomplished executive and entrepre...

Horizon Pharma plc to Present at the 37th Annual J.P. Morgan Healthcare Conference

Horizon Pharma plc (Nasdaq: HZNP) announced today that the company will participate in the 37th Annual J.P. Morgan Healthcare Conference. Timothy P. Walbert, chairman, president and chief executive officer, will present at 4:30 p.m. PT on Jan. 8, 2019. The conference presentation will be webcast live and may be accessed by visiting Horiz...


Tilray® Signs Letter of Intent for Hemp-Derived CBD from the U.S. and Canada

Company to utilize CBD isolate for distribution of wellness and medical products across North America Tilray, Inc. (NASDAQ:TLRY), a global leader in cannabis research and production, today announced the terms of a binding letter of intent (“LOI”) to purchase hemp-derived CBD isolate from LiveWell Canada Inc. (CSE:LVWL) (“LiveWell”), which ...

EVIO Labs Receives Provisional License from Massachusetts Cannabis Control Commission

Independent testing laboratory in final phase to perform state compliance testing EVIO Inc. (“EVIO” or the “Company”), (OTCQB: EVIO), a leading provider of cannabis testing and research for the regulated cannabis industry in North America announced today that it received a provisional license from Massachusetts Cannabis Control Commission ...

Hardman & Co Research: Tissue Regenix (TRX): 2018 in review: foundations laid for osteobiologics

Hardman & Co Research 17-Dec-2018 / 11:56 GMT/BST Hardman & Co: 2018 in review: foundations laid for osteobiologics TRX has a broad portfolio of regenerative medicine products for the biosurgery, orthopaedics, dental and cardiac markets. It has two proprietary decellularisation technology platforms for the repair of soft tissue (dCELL) and bone (BioRinse). With organic growth being b...

Novocure and the AACR Announce Four Inaugural Research Grants to Promote and Support Innovative Research on Tumor Treating Fields

Novocure (NASDAQ: NVCR) and the American Association for Cancer Research (AACR) announce four inaugural Tumor Treating Fields research grants. The grants represent a joint effort to promote and support innovative research on Tumor Treating Fields. Tumor Treating Fields is a cancer therapy that uses electric fields tuned to specific frequencies to disrupt c...

Surrey Clinical Research Centre expand contract with OmniComm Systems

Surrey Clinical Research, an MHRA Phase I accredited facility with expertise in Phase I, first-in-human, through to Phase IV, has used Promasys since 2014, and the new agreement The post Surrey Clinical Research Centre expand contract with OmniComm Systems appeared first on Compelo Medical Devices.

Our 5 biggest cancer research stories from 2018

Science blog It’s been another busy year in cancer research. From taking important steps towards tackling the most aggressive cancers to making treatments kinder for children, these are our 5 biggest research stories from 2018. 1. A spotlight on brain tumours Brain tumours have been hard to treat for too long, with only 1 in 7 people surviving their disease for a decade or longer. That’s wh...

Renewi (RWI) - Near-term trading distracting from long-term trend

Edison Investment Research - Industrial Support Services - Renewi: Longer-term recycling trends remain favourable and the next phase of strategic development indicates greater focus in core areas to pursue growth. In the near term, we acknowledge that ATM will be a distraction until full permit authority is formally restored and is weighing on our earnings expectations, which have stepped down by ...

The Trump administration is pushing to find alternatives to fetal tissue for research — but at least right now, scientists warn that there aren't any good ones. https://buff.ly/2CizlJa 

The Trump administration is pushing to find alternatives to fetal tissue for research — but at least right now, scientists warn that there aren't any good ones. https://buff.ly/2CizlJa 

Bristol-Myers Squibb and H3 Biomedicine Announce Research Collaboration to Advance Novel Therapeutics Leveraging H3’s RNA Splicing Platform

Bristol-Myers Squibb Company (NYSE: BMY), Eisai Co., Ltd. (Headquarters: Tokyo, CEO: Haruo Naito, “Eisai”) and its U.S.-based precision medicine research & development subsidiary

Sun Care Market is Expected to Reach US$24. ...

ALBANY, New York, December 17, 2018 /PRNewswire/ -- The global sun care market is expected to experience steady growth in Transparency Market Research (TMR). The Read more...

Ludwig Institute For Cancer Research Ltd Pharmaceuticals Healthcare Deals and Alliances Profile [Report Updated: 08112018] Prices from USD $250

SummaryLudwig Institute for Cancer Research Ltd LICR is a nonprofit organization that conducts cancer research and clinical trial programs. The organization carries out research in the areas of clinical trials, genomics, cell biology, immunology, neuroscience, signaling, therapeutics, stem cells and tumor biology, among others. It provides patents, licensing, contracts, portfolio development, clin...

Cambridge Researchers Developing Self-Healing Concrete

Researchers at the University of Cambridge are using microencapsulation technologies developed by Dolomite Microfluidics to develop self-healing construction materials. As highlighted in recent BBC News broadcasts, the Department of Engineering’s Geotechnical and Environmental Research Group is developing microcapsules containing ‘healing’ agents – such as minerals, epoxy o...

Mobidiag Announces Joint Venture with Autobio Diagnostics and €10m Equity Investment

JV will acquire a license to commercialise Novodiag® platform in the Greater China territory €10m investment to fund the continued expansion of Mobidiag’s product portfolio and further accelerate commercial development Mobidiag Ltd., a commercial stage molecular diagnostics company addressing the spread of antimicrobial resistance, today ...

Idera Pharmaceuticals Inc IDRA Pharmaceuticals Healthcare Deals and Alliances Profile [Report Updated: 09112018] Prices from USD $250

SummaryIdera Pharmaceuticals Inc. Idera is a clinical stage biopharmaceutical company, which focuses on the discovery, development and commercialization of drugs for the treatment of cancer and rare diseases. It develops DNA and RNA based drug candidates aimed at tolllike receptors TLR for the treatment of infectious diseases and for use as vaccine adjuvants. The company initiated a research progr...

There aren’t any good alternatives to fetal tissue research, scientists warn

The Trump administration is pushing to find alternatives to fetal tissue for research — but at least right now, scientists warn that there aren't any good ones.

Global Dermatology Lasers Market 2019-2023 | Industry Analysis and Forecast | Technavio

The global dermatology lasers market research report by Technavio predicts the market to post a CAGR of more than 14% during the period 2019-2023. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20181217005248/en/

Pharmakonzern Abbott hebt die Dividende das 47. Jahr in Folge an

Der amerikanische Pharmakonzern Abbott Laboratories (ISIN: US0028241000, NYSE: ABT) steigert seine Quartalsdividende um vier US-Cents oder 14 Prozent auf 32 US-Cents je Aktie. Dies ist die 47. Jähr...

Cancer Research Highlight: Exelixis Kicks Off A New Collaboration With Roche

Global Dental Cleansing Tablet Market 2019-2023 | Rising Access to Distribution Channels to Boost Growth | Technavio

Technavio’s global dental cleansing tablet market research report forecasts the market to grow at a CAGR of around 6% during the forecast period. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20181216005067/en/

Loughborough academics part of new project investigating effectiveness of personalized breast cancer screening

Loughborough University academics are to conduct research as part of a large-scale international project investigating whether personalized breast cancer screening is a better screening option for women aged 40 to 70.

Icagen Inc Pharmaceuticals Healthcare Deals and Alliances Profile [Report Updated: 13112018] Prices from USD $250

SummaryIcagen Inc Icagen formerly known as XRpro Sciences, Inc. is a biopharmaceutical company which develops drug candidates to unmet medical needs. The company discovers drug for clinical stage across multiple therapeutics and ion class channel classes. The company provides technologies including manual and automated electrophysiology, high throughput fluorescence and radiotracer flux assays. It...

A Story of Innovative Molecules: From Machines to Cyclic Compounds

2016 Nobel Laureate in Chemistry Fraser Stoddart outlines his research involving mechanically interlocked molecules and molecular machines, and introduces the work of some of the students in his lab, to be discussed at Pittcon 2018.


Advertisement
Quick Search
Advertisement
Advertisement

 

News Quicklinks